Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Technology | 14.17% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4076
US Global Investors
GROW
$33.2M
| $39K | ﹤0.01% |
26,146
+818
| +3% | +$1.17K |
2013 Q2
16 quarters
|
|
4077
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $39K | ﹤0.01% |
48,607
-2,679
| -5% | -$214K |
2016 Q1
5 quarters
|
|
4078
Tenax Therapeutics
TENX
$54.6M
| $38K | ﹤0.01% |
2
| – | – |
2014 Q1
13 quarters
|
|
|
LOV
4079
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $37K | ﹤0.01% |
38,841
| – | – |
2013 Q2
16 quarters
|
|
4080
Aethlon Medical
AEMD
$3.67M
| – | – |
0
| – | – |
2016 Q3
3 quarters
|
|
4081
Altimmune
ALT
$453M
| $36K | ﹤0.01% |
379
-1,835
| -83% | -$305K |
2013 Q2
16 quarters
|
|
4082
Astrotech Corp
ASTC
$10.4M
| $36K | ﹤0.01% |
268
| – | – |
2013 Q2
16 quarters
|
|
4083
Energy Focus
EFOI
$17.9M
| $36K | ﹤0.01% |
393
| – | – |
2016 Q1
5 quarters
|
|
4084
XWELL
XWEL
$7.58M
| $35K | ﹤0.01% |
18
| – | – |
2016 Q2
4 quarters
|
|
4085
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $35K | ﹤0.01% |
138
| – | – |
2014 Q1
13 quarters
|
|
4086
B2Gold
BTG
$7.04B
| $34K | ﹤0.01% |
12,141
| – | – |
2014 Q3
11 quarters
|
|
4087
XMAX Inc
XMAX
$554M
| $34K | ﹤0.01% |
904
| – | – |
2014 Q1
13 quarters
|
|
|
TVIA
4088
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $34K | ﹤0.01% |
148,120
-626,590
| -81% | -$226K |
2016 Q2
4 quarters
|
|
4089
DELISTED
Repros Therapeutics Inc.
RPRX
| $34K | ﹤0.01% |
76,187
-623
| -0.8% | -$453 |
2013 Q2
16 quarters
|
|
4090
DELISTED
ProPhase Labs
PRPH
| $33K | ﹤0.01% |
1,584
+188
| +13% | +$3.77K |
2015 Q3
7 quarters
|
|
4091
DELISTED
Streamline Health Solutions
STRM
| $33K | ﹤0.01% |
2,090
| – | – |
2013 Q2
16 quarters
|
|
|
AMRS
4092
DELISTED
Amyris Inc.
AMRS
| $33K | ﹤0.01% |
10,278
+4
| +0% | +$22 |
2013 Q2
16 quarters
|
|
4093
DELISTED
Carisma Therapeutics
CARM
| $32K | ﹤0.01% |
1,030
| – | – |
2016 Q3
3 quarters
|
|
4094
DELISTED
CASI Pharmaceuticals
CASI
| $32K | ﹤0.01% |
3,103
| – | – |
2014 Q3
11 quarters
|
|
|
MBII
4095
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $32K | ﹤0.01% |
24,738
| – | – |
2013 Q3
15 quarters
|
|
|
IMI
4096
DELISTED
Intermolecular, Inc.
IMI
| $32K | ﹤0.01% |
35,926
| – | – |
2013 Q2
16 quarters
|
|
4097
Aemetis
AMTX
$109M
| $31K | ﹤0.01% |
23,213
| – | – |
2014 Q3
11 quarters
|
|
4098
Koss Corp
KOSS
$34.8M
| $31K | ﹤0.01% |
16,927
+1,188
| +8% | +$2.31K |
2013 Q2
16 quarters
|
|
4099
Retractable Technologies
RVP
$17.6M
| $31K | ﹤0.01% |
24,594
| – | – |
2014 Q1
13 quarters
|
|
4100
iShares 1-3 Year Treasury Bond ETF
SHY
$26.9B
| $31K | ﹤0.01% |
37,205
+8,825
| +31% | +$746K |
2013 Q2
16 quarters
|
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.